Contributions
Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients
Margaret J. Gorensek, MD, William D. Carey, MD, John A. Washington, MD, David P. Vogt, MD, Thomas A. Broughan, MD and Mary Kay Westveer, RN
Cleveland Clinic Journal of Medicine March 1993, 60 (2) 139-144;
Margaret J. Gorensek
Department of Infectious Diseases, Cleveland Clinic Florida
William D. Carey
Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland.
John A. Washington II
Department of Microbiology, The Cleveland Clinic Foundation, Cleveland.
David P. Vogt
Department of General Surgery, The Cleveland Clinic Foundation, Cleveland.
Thomas A. Broughan
Department of General Surgery, The Cleveland Clinic Foundation, Cleveland.
Mary Kay Westveer
Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland.

Article Information
vol. 60 no. 2 139-144
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online March 1, 1993.
Copyright & Usage
Copyright © 1993 The Cleveland Clinic Foundation. All Rights Reserved.
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 60, Issue 2
1 Mar 1993
Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients
Margaret J. Gorensek, William D. Carey, John A. Washington, David P. Vogt, Thomas A. Broughan, Mary Kay Westveer
Cleveland Clinic Journal of Medicine Mar 1993, 60 (2) 139-144;
Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients
Margaret J. Gorensek, William D. Carey, John A. Washington, David P. Vogt, Thomas A. Broughan, Mary Kay Westveer
Cleveland Clinic Journal of Medicine Mar 1993, 60 (2) 139-144;
Jump to section
Related Articles
- No related articles found.





